GE Healthcare’s India Edison Accelerator enrols six startups
The start-ups of the second cohort will focus on point-of-care diagnostics, remote patient monitoring, virtual hospitals, data management and insights and asset health monitoring
‘India Edison Accelerator – Startups powered by GE Healthcare’ announced the launch of its second cohort, with the enrollment of six health-tech startups — AarogyaAI, BrainSightAI, Fluid AI, InMed Prognostics, Wellthy Therapeutics and Onward Assist. In its second year now, India Edison Accelerator, the company’s first startup collaboration programme based out of India is committed to mentoring and creating strategic partners to co-develop healthcare solutions alongside GE’s engineers and scientists.
Riding on the success of the first Cohort of the programme, this time the focus is on technology solutions aimed at streamlining healthcare delivery across verticals- advanced imaging and visualisation, precision diagnosis and treatment, computer-aided detection and diagnosis, point-of-care diagnostics, remote patient monitoring, virtual hospitals, data management and insights and asset health monitoring.
Girish Raghavan, VP, Software Engineering, GE Healthcare South Asia said, “The aim of this programme is to harness the brainpower of the start-up ecosystem for developing solutions on the Edison platform for some of the toughest healthcare challenges existing today. We are excited about the second Cohort of ‘India Edison Accelerator – Startups powered by GE Healthcare’ and the collaboration that we are already seeing between the startup community, our colleagues and the Edison platform itself.”
The applications received were screened through a three-stage process and the shortlisted entries were evaluated based on the strength of the business idea/plan, maturity and the closeness to productise their solution, team capabilities and relevance to defined focus areas among others. ‘India Edison Accelerator – Startups powered by GE Healthcare’ is providing a zero-equity cash-in-grant of $10000 to each of the selected startups. In addition, they will have access to mentorship, skill development programs, commercial and regulatory guidance, and data provision as additional benefits.
Recommended
KKR moves closer to acquisition of HCG
December 14, 2024
Cipla receives CDSCO approval for inhaled insulin Afrezza
December 13, 2024